US Stock MarketDetailed Quotes
ACET Adicet Bio
- 1.110
- +0.150+15.59%
Close Nov 27 16:00 ET
- 1.060
- -0.050-4.50%
Post 18:52 ET
91.47MMarket Cap-652P/E (TTM)
1.120High0.960Low1.31MVolume0.990Open0.960Pre Close1.35MTurnover2.11%Turnover RatioLossP/E (Static)82.40MShares3.77052wk High0.43P/B68.93MFloat Cap0.88652wk Low--Dividend TTM62.10MShs Float214.348Historical High--Div YieldTTM16.66%Amplitude0.886Historical Low1.032Avg Price1Lot Size
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Profile
SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com
Company Executives
- Name
- Position
- Salary
- Chen Schor, M.B.A.
- Chief Executive Officer, President and Director
- 3.99M
- Dr. Blake Aftab, PhD
- Chief Scientific Officer
- 2.48M
- Nick Harvey
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Donald Healey, PhD
- Chief Technology Officer
- --
- Dr. Francesco Galimi, M.D.,PhD
- Chief Medical Officer
- 1.99M
- Katie Peng
- Independent Director
- --
- Dr. Andrew Sinclair, PhD
- Independent Director
- 194.37K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 218.87K
- Dr. Aya Jakobovits, PhD
- Independent Director
- 183.87K
- Steve Dubin, J.D.
- Independent Director
- 197.87K
- Dr. Lloyd Klickstein, M.D.,PhD
- Independent Director
- --
- Dr. Jeffrey A. Chodakewitz, M.D.
- Independent Director
- 183.87K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data